Spruce Biosciences, Inc (SPRB) insider trading
Every open-market stock purchase and sale by Spruce Biosciences, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $9.8K over the last 12 months (2 sales).
- Last insider buy: Parkman Healthcare Partners LLC (10% owner), $4.6K, 12 months ago.
Last 12 months: insiders bought $9.2K (2 buys) and sold $9.8K (2 sales). Last close $43.37 on Jul 30, 2026.
Recent SPRB insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jul 27, 2026 | Adrian W Quartel (C-suite exec) | Bought (not open market) | — |
| Jun 30, 2026 | Javier B. Szwarcberg (CEO) | Bought (not open market) | $1.2K |
| May 21, 2026 | Keli Walbert (Insider) | Bought (not open market) | — |
| May 21, 2026 | Camilla V Simpson (Insider) | Bought (not open market) | — |
| May 21, 2026 | Daniel K Spiegelman (Insider) | Bought (not open market) | — |
| May 21, 2026 | Percival Barretto-Ko (Insider) | Bought (not open market) | — |
| May 21, 2026 | Michael G Grey (Chair) | Bought (not open market) | — |
| Mar 9, 2026 | Corwin Dale Hooks (C-suite exec) | Bought (not open market) | — |
| Dec 31, 2025 | Javier B. Szwarcberg (CEO) | Bought (not open market) | $21.2K |
| Dec 15, 2025 | Javier B. Szwarcberg (CEO) | Sold (not open market) | $60.7K |
| Dec 15, 2025 | Javier B. Szwarcberg (CEO) | Sold (not open market) | $49K |
| Dec 15, 2025 | Samir M. Gharib (CFO) | Sold (not open market) | $14.8K |
| Dec 15, 2025 | Samir M. Gharib (CFO) | Sold (not open market) | $14.4K |
| Dec 15, 2025 | Samir M. Gharib (CFO) | Bought (not open market) | — |
| Dec 15, 2025 | Javier B. Szwarcberg (CEO) | Bought (not open market) | — |
| Dec 15, 2025 | Javier B. Szwarcberg (CEO) | Bought (not open market) | — |
| Dec 15, 2025 | Samir M. Gharib (CFO) | Bought (not open market) | — |
| Dec 11, 2025 | Javier B. Szwarcberg (CEO) | Sold (not open market) | $3.4M |
| Dec 11, 2025 | Samir M. Gharib (CFO) | Sold (not open market) | $1.1M |
| Dec 11, 2025 | Javier B. Szwarcberg (CEO) | Bought (not open market) | $1M |
| Dec 11, 2025 | Javier B. Szwarcberg (CEO) | Sold (not open market) | $574K |
| Dec 11, 2025 | Samir M. Gharib (CFO) | Sold (not open market) | $360K |
| Dec 11, 2025 | Michael G Grey (Chair) | Sold (not open market) | $345K |
| Dec 11, 2025 | Samir M. Gharib (CFO) | Sold (not open market) | $321K |
| Dec 11, 2025 | Daniel K Spiegelman (Insider) | Sold (not open market) | $258K |
Who's trading SPRB
- Adrian W Quartel, C-suite exec: other filings, last Jul 27, 2026
- Javier B. Szwarcberg, CEO: other filings, last Jun 30, 2026
- Michael G Grey, Chair: other filings, last May 21, 2026
- Daniel K Spiegelman, Insider: other filings, last May 21, 2026
- Percival Barretto-Ko, Insider: other filings, last May 21, 2026
- Keli Walbert, Insider: other filings, last May 21, 2026
- Camilla V Simpson, Insider: other filings, last May 21, 2026
- Corwin Dale Hooks, C-suite exec: other filings, last Mar 9, 2026
- Samir M. Gharib, CFO: other filings, last Dec 15, 2025
- Douglas Kirk Ways, C-suite exec: other filings, last Dec 11, 2025
- Parkman Healthcare Partners LLC, 10% owner: bought $9.2K (2 buys), sold $9.8K (4 sales), last Oct 6, 2025
Get free alerts when an insider at Spruce Biosciences, Inc files a new trade →